COST BENEFIT ANALYSIS;
DRUG COST;
DRUG USE;
EDITORIAL;
HEALTH CARE;
HEALTH CARE DELIVERY;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HEALTH PROGRAM;
HUMAN;
INCOME;
MEDICARE;
PHARMACEUTICAL CARE;
PRESCRIPTION;
PRIORITY JOURNAL;
AGED;
ATTITUDE TO HEALTH;
COST;
DRUG UTILIZATION;
ECONOMICS;
NOTE;
TREATMENT REFUSAL;
UNITED STATES;
AGED;
COST SHARING;
DRUG COSTS;
DRUG UTILIZATION;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HUMANS;
INSURANCE, MEDIGAP;
MEDICARE PART D;
TREATMENT REFUSAL;
UNITED STATES;
Baltimore, MD: Centers for Medicare & Medicaid Services;
The 2008 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. Baltimore, MD: Centers for Medicare & Medicaid Services; 2008.
Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs
Hsu J, Fung V, Price M, et al. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. JAMA. 2008;299(16):1929-1936.
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D
Madden JM, Graves AJ, Zhang F, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008;299(16):1922-1928.
Centers for Medicare & Medicaid Services. Management Information Integrated Repository. http://www.cms.hhs.gov/PrescriptionDrugCovGenIn/. Accessed January 18, 2008.
Baltimore, MD: Centers for Medicare & Medicaid Services;
The 2007 Annual Report of the Boards of Trustees of the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds. Baltimore, MD: Centers for Medicare & Medicaid Services; 2007.
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures
Yin W, Basu A, Zhang JX, Rabbani A, Meltzer DO, Alexander GC. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med. 2008;148(3):169-177.
Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia
Soumerai SB, McLaughlin TJ, Ross-Degnan D, Casteris CS, Bollini P. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med. 1994;331(10):650-655.
(1994)N Engl J Med, vol.331, Issue.10, pp. 650-655
